The impact of Hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 33, Issue 3, 2003, Pages 365-372

  Klein, Marina B ^a   Lalonde, Richard G ^a   Suissa, Samy ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Antiretroviral therapy; Hepatitis C virus; Injection drug use; Progression; Survival

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; EXPERIENCE; FEMALE; HEALTH INSURANCE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; VIRUS LOAD;

EID: 0038163753     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200307010-00011     Document Type: Article

References (21)

1. Bureau of HIV/AIDS, STD and TB, Centre for Infectious Disease Prevention and Control, Health Canada, HIV/AIDS cases among injecting drug users in Canada. HIV/AIDS Epi Update. 2001.
2. Macias J, Pineda JA, Leal M, et al. Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease. Eur J Clin Micro Infect Dis. 1998;17:167-170.
3. Baubuderi S, Cossu PA, Tocco A, et al. Course of patients coinfected with HIV and hepatotropic viruses. Hepatology. 1994;20: A255.
4. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus co-infection: the Swiss Cohort Study. Lancet. 2000;356:1800-1805.
5. Sulkowski MS, Moore RD, Mehta SH, et al. Hepatitis C and progression of HIV disease. JAMA. 2002;288:199-205.
6. Palella FJ, Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
7. Hogg RS, Yip B, Kully C. Improved survival among HIV-infected patients after initiation of triple drug antiretroviral regimens. CMAJ. 1999;160:659-665.
8. Vento S, Garofano T, Renzini, et al. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. AIDS. 1998;12:116-117.
9. Rutschmann OT, Negro F, Hirschel B, et al. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients co-infected with HIV. J Infect Dis. 1998;177:783-785.
10. Zylberberg H, Pialoux G, Carnot F, et al. Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy. Clin Infect Dis. 1998;27:1255-1258.
11. Centers for Disease Control and Prevention. 1993 revised HIV classification system and expanded AIDS surveillance definition for adolescents adults. MMWR Morb Mortal Wkly Rep. 1992;41: RR-17.
12. Murphy DG, Cote L, Fauvel M, et al. Multicenter comparison of Roche Amplicor Monitor version 1.5, Organon Teknika NucliSens QT with extractor and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 2000;38:4034-4041.
13. US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. US Department of Health and Human Services, 2000.
14. Wright TL, Hollander H, Pu X, et al. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology. 1994;20:1152-1155.
15. Piroth L, Duong M, Quantin C, et al. Does hepatitis C coinfection accelerate the clinical and immunologic evolution of HIV-infected patients? AIDS. 1998;12:381-388.
16. Ockenga J, Tillmann HL, Trautwein C, et al. Hepatitis B and C in HIV infected patients. J Hepatol. 1997;27:18-24.
17. Zylberberg H, Chaix ML, Rabian C, et al. Tritherapy for human immunodeficiency virus does not modify replication of hepatitis C virus in coinfected subjects. Clin Infect Dis. 1998;26:1104-1106.
18. Rockstroh JK, Theisen A, Kaiser R, et al. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs. AIDS. 1998;12:829-830.
19. Woitas RP, Rockstroh JK, Beier I, et al. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients. AIDS. 1999;38:1313-1322.
20. Laskus T, Radkowski M, Piasek A, et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence for active replication in monocyte/macrophages and lymphocytes. J Infect Dis. 2000;181:442-448.
21. Frischer M, Bloor M, Goldberg D, et al. Mortality among injecting drug users. A critical reappraisal. J Epidemiol Community Health. 1993;47:59-63.